Abstract
Herpes zoster (HZ, also known as shingles) is caused by the reactivation of a dormant varicella zoster virus and can be a source of significant morbidity. Oral manifestations can include vesicular eruptions of the mucosa, osteonecrosis with tooth loss, and postherpetic neuralgia (PHN). This article discusses treatment for trigeminal nerve involvement with herpes zoster, as well as for the painful syndrome PHN.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antiviral Agents / therapeutic use
-
Herpes Zoster / complications
-
Herpes Zoster / prevention & control*
-
Herpes Zoster / therapy
-
Herpes Zoster Vaccine / therapeutic use
-
Humans
-
Jaw Diseases / prevention & control
-
Jaw Diseases / therapy
-
Jaw Diseases / virology
-
Male
-
Middle Aged
-
Mouth Diseases / etiology
-
Mouth Diseases / therapy
-
Mouth Diseases / virology*
-
Neuralgia, Postherpetic / prevention & control*
-
Neuralgia, Postherpetic / therapy
-
Neuralgia, Postherpetic / virology
-
Osteonecrosis / prevention & control
-
Osteonecrosis / therapy
-
Osteonecrosis / virology*
-
Trigeminal Neuralgia / prevention & control
-
Trigeminal Neuralgia / therapy
-
Trigeminal Neuralgia / virology*
Substances
-
Antiviral Agents
-
Herpes Zoster Vaccine